Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dilactide
2. Lactide
1. Dl-lactide
2. 95-96-5
3. Lactide
4. Dilactide
5. 1,4-dioxane-2,5-dione, 3,6-dimethyl-
6. 3,6-dimethyl-2,5-dioxo-1,4-dioxane
7. P-dioxane-2,5-dione, 3,6-dimethyl-
8. Lactic Acid, Bimol. Cyclic Ester
9. Dl-dilactide
10. 26680-10-4
11. Propanoic Acid, 2-hydroxy-, Bimol. Cyclic Ester
12. 7eh08mwo6m
13. Nsc-403080
14. 33135-50-1
15. Purasorb Dl; Dl-dilactide; Rac-lactide
16. Einecs 202-468-3
17. Unii-7eh08mwo6m
18. Nsc 403080
19. Lactid
20. Hexythlazox
21. Rac-lactide
22. Ai3-05059
23. Mfcd00070594
24. Mfcd00082566
25. L-polylactide(plla)
26. Dimethylglycolide
27. 3,6-dimethyl-[1,4]dioxane-2,5-dione
28. Lactide, Dl-
29. Ec 202-468-3
30. 3,5-dioxo-1,4-dioxane
31. Dsstox_cid_21253
32. Dsstox_rid_79665
33. 3,6-dimethyl-1,4-dioxane-2,5-dione Homopolymer
34. Dsstox_gsid_41253
35. Schembl15034
36. 1,5-dione, 3,6-dimethyl-
37. P-dioxane-2, 3,6-dimethyl-
38. Chembl3185272
39. Dtxsid7041253
40. Chebi:177651
41. Bcp34367
42. Propanoic Acid, Bimol. Cyclic Ester
43. Tox21_302164
44. Mfcd00011685
45. Nsc403080
46. L-polylactide(plla);l-(-)-lactide
47. Akos005206744
48. Cas-95-96-5
49. Ncgc00255679-01
50. As-17933
51. Sy026985
52. Sy060845
53. Dl-3,6-dimethyl-1,4-dioxane-2,5-dione
54. L-3,6-dimethyl-1,4-dioxane-2,5-dione
55. 3,6-dimethyl-p-dioxane-2,5-dione
56. Db-070627
57. Db-080384
58. Ft-0601997
59. Ft-0625454
60. L0091
61. 2,5-dimethyl-3,6-dioxo-1,4-dioxane
62. D81885
63. A826719
64. Q421313
65. (3s)-cis-3,6-dimethyl-1,4-dioxane-2,5-dione 98%
Molecular Weight | 144.12 g/mol |
---|---|
Molecular Formula | C6H8O4 |
XLogP3 | 0.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 144.04225873 g/mol |
Monoisotopic Mass | 144.04225873 g/mol |
Topological Polar Surface Area | 52.6 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 155 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 2 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19103
Submission : 2005-10-28
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19102
Submission : 2005-10-28
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12983
Submission : 1998-04-27
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37673
Submission : 2022-12-08
Status : Active
Type : IV
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
A L-Lactide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Lactide, including repackagers and relabelers. The FDA regulates L-Lactide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Lactide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Lactide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Lactide supplier is an individual or a company that provides L-Lactide active pharmaceutical ingredient (API) or L-Lactide finished formulations upon request. The L-Lactide suppliers may include L-Lactide API manufacturers, exporters, distributors and traders.
click here to find a list of L-Lactide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A L-Lactide DMF (Drug Master File) is a document detailing the whole manufacturing process of L-Lactide active pharmaceutical ingredient (API) in detail. Different forms of L-Lactide DMFs exist exist since differing nations have different regulations, such as L-Lactide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A L-Lactide DMF submitted to regulatory agencies in the US is known as a USDMF. L-Lactide USDMF includes data on L-Lactide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The L-Lactide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of L-Lactide suppliers with USDMF on PharmaCompass.
L-Lactide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Lactide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Lactide GMP manufacturer or L-Lactide GMP API supplier for your needs.
A L-Lactide CoA (Certificate of Analysis) is a formal document that attests to L-Lactide's compliance with L-Lactide specifications and serves as a tool for batch-level quality control.
L-Lactide CoA mostly includes findings from lab analyses of a specific batch. For each L-Lactide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Lactide may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Lactide EP), L-Lactide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Lactide USP).
LOOKING FOR A SUPPLIER?